Frequently Asked Questions
The market is segmented based on Global Brain Disease Imaging and Software Market, By Type (Imaging Devices and Software), Application (Alzheimer's Disease, Dementia, Stroke, Multiple Sclerosis, Parkinson's Disease, Brain Tumors, Epilepsy and Traumatic Brain Injury (TBI)), Patient Type (Adults, Pediatrics, and Infants), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Imaging Centers, and Research Institutions) – Industry Trends and Forecast to 2031.
.
The Global Brain Disease Imaging And Software Market size was valued at USD 14.22 USD Billion in 2023.
The Global Brain Disease Imaging And Software Market is projected to grow at a CAGR of 5.2% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa.
